Informal gatherings: A perspective from the Berlin and Brandenburg group.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 119
- By:
- Publication type:
- Article
Works matching IS 20474806 AND DT 2019 AND VI 28 AND IP 2
Results: 48
1
2
The Erasmus programme: Not only about students, new entrepreneurs can benefit too.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 122
- By:
- Publication type:
- Article
3
The SciMed Writers Network: Fostering local medical writers' camaraderie in the Netherlands.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 120
- By:
- Publication type:
- Article
4
Out on Our Own.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 119
- By:
- Publication type:
- Article
5
Status updates - from regulatory regions.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 117
- Publication type:
- Article
6
An introduction to the vivli.org data sharing platform.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 117
- By:
- Publication type:
- Article
7
A nutshell guide to the Health Canada guidance on public release of clinical information.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 116
- By:
- Publication type:
- Article
8
Regulatory Public Disclosure.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 116
- By:
- Publication type:
- Article
9
Syntactic inter-sentence distraction Omission: Continuity markers.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 114
- By:
- Publication type:
- Article
10
Journal Watch.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 110
- By:
- Publication type:
- Article
11
One drug, many benefits: Promising outcomes from a new class of antidiabetic drugs.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 108
- By:
- Publication type:
- Article
12
The next medical device scandal: Medical device files - my personal view (Part 2).
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 104
- By:
- Publication type:
- Article
13
The teaching of medical writing has arrived!
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 102
- By:
- Publication type:
- Article
14
Transparency on controversial topics: What medical writing can learn from vets.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 101
- By:
- Publication type:
- Article
15
Medical writing: A walk through my career journey.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 98
- By:
- Publication type:
- Article
16
New add-on treatment to insulin for treatment of certain patients with type 1 diabetes.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 97
- By:
- Publication type:
- Article
17
EMA confirms omega-3 fatty acid medicines are not effective in preventing further heart problems after a heart attack.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 96
- By:
- Publication type:
- Article
18
First treatment for rare disease characterised by high levels of triglycerides in blood.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 96
- By:
- Publication type:
- Article
19
New add-on treatment for patients with severe asthma.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 95
- By:
- Publication type:
- Article
20
European Union and Switzerland to improve information-sharing on good manufacturing practice through use of EudraGMDP database.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 95
- By:
- Publication type:
- Article
21
New safety features for medicines sold in the European Union.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 94
- By:
- Publication type:
- Article
22
Regulatory Matters: A brief look at biosimilars in the United States.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 93
- By:
- Publication type:
- Article
23
The medical writer: Partner or servant? From an academic who took communication for granted.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 92
- By:
- Publication type:
- Article
24
Statistical principles in biosimilar development.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 28
- By:
- Publication type:
- Article
25
Biosimilar development - an overview.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 20
- By:
- Publication type:
- Article
26
Regulatory pathways for development and submission activities.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 8
- By:
- Publication type:
- Article
27
Writing biosimilar clinical study reports and submission documents - what to expect and what to consider.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 33
- By:
- Publication type:
- Article
28
Winner of the Geoff Hall Scholarship Essay Competition.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 91
- By:
- Publication type:
- Article
29
Document management systems for medical writing.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 88
- By:
- Publication type:
- Article
30
Collecting metrics in medical writing - the benefits to you and your business.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 85
- By:
- Publication type:
- Article
31
Publication of clinical trial protocols and statistical analysis plans on ClinicalTrials.gov.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 81
- By:
- Publication type:
- Article
32
Medicinal products and medical devices in clinical trials conduct and disclosure - and never the twain shall meet!
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 74
- By:
- Publication type:
- Article
33
International Committee of Medical Journal Editors' requirements for sharing individual participant data from interventional clinical trials.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 66
- By:
- Publication type:
- Article
34
Biosimilars: Change, challenge, and accomplishments.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 60
- By:
- Publication type:
- Article
35
Insulin biosimilars.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 57
- By:
- Publication type:
- Article
36
Layperson materials in the sphere of biosimilars and generic medicines.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 53
- By:
- Publication type:
- Article
37
Same but different: Basic tools for biosimilar and generic pharmacovigilance writing.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 45
- By:
- Publication type:
- Article
38
Medical writing for generics throughout the life cycle.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 39
- By:
- Publication type:
- Article
39
A new Special Interest Group on medical communications!
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 7
- By:
- Publication type:
- Article
40
President's Message From EMWA President 2019-2020.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 5
- By:
- Publication type:
- Article
41
President's Message From EMWA President 2018-2019.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 4
- By:
- Publication type:
- Article
42
Thanks You James!
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 3
- By:
- Publication type:
- Article
43
Thanks You James!
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 3
- By:
- Publication type:
- Article
44
EMWA News.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 6
- By:
- Publication type:
- Article
45
Thank You, James!
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 3
- By:
- Publication type:
- Article
46
Thank You, James!
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 2
- By:
- Publication type:
- Article
47
Generics and biosimilars.
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 1
- By:
- Publication type:
- Article
48
Thank You James!
- Published in:
- Medical Writing, 2019, v. 28, n. 2, p. 2
- By:
- Publication type:
- Article